Zhitong Finance App News, Medical Pulse (02192) announced that the company will begin to repurchase the company's shares in the open market on October 26, 2026. The share repurchase was carried out in accordance with the general share repurchase authorization granted by the company's shareholders at the annual general meeting of shareholders held on May 15, 2026. The repurchase capital comes from the company's internal resources.

The company believes that the company's current stock price level does not fully reflect its long-term value. After evaluating the company's long-term development prospects and carefully considering shareholders' interests, the company will carefully and orderly implement in-market share repurchase arrangements within the scope of the repurchase authorization and on the premise of complying with applicable laws, regulations and regulatory requirements.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.